loadpatents
Patent applications and USPTO patent grants for Nutt; Ruth F..The latest application filed is for "thiazole and thiadiazole inhibitors of tyrosine phosphatases".
Patent | Date |
---|---|
Thiazole And Thiadiazole Inhibitors Of Tyrosine Phosphatases App 20080200371 - CHERUVALLATH; Zacharia S. ;   et al. | 2008-08-21 |
Thiazole and thiadiazole inhibitors of tyrosine phosphatases Grant 7,381,736 - Cheruvallath , et al. June 3, 2 | 2008-06-03 |
Inhibitors of anthrax lethal factor App 20070197577 - Rideout; Darryl ;   et al. | 2007-08-23 |
Thiazole and thiadiazole inhibitors of tyrosine phosphatases App 20060194768 - Cheruvallath; Zacharia S. ;   et al. | 2006-08-31 |
Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases App 20060135483 - Cheruvallath; Zacharia S. ;   et al. | 2006-06-22 |
Trisubstituted nitrogen modulators of tyrosine phosphatases App 20060135773 - Semple; Joseph E. ;   et al. | 2006-06-22 |
Method and system for artificial intelligence directed lead discovery through multi-domain clustering Grant 6,904,423 - Nicolaou , et al. June 7, 2 | 2005-06-07 |
Aromatic heterocyclic derivatives as enzyme inhibitors Grant 6,011,158 - Tamura , et al. January 4, 2 | 2000-01-04 |
3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors Grant 5,932,733 - Semple , et al. August 3, 1 | 1999-08-03 |
Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors Grant 5,681,844 - Abelman , et al. October 28, 1 | 1997-10-28 |
Thrombin inhibitors Grant 5,672,582 - Veber , et al. September 30, 1 | 1997-09-30 |
Methionine sulfone and S-substituted cysteine sulfone derivatives as enzyme inhibitors Grant 5,646,165 - Abelman , et al. July 8, 1 | 1997-07-08 |
Arginine mimic derivatives as enzyme inhibitors Grant 5,637,599 - Levy , et al. June 10, 1 | 1997-06-10 |
Fibrinogen receptor antagonists Grant 5,340,798 - Nutt , et al. August 23, 1 | 1994-08-23 |
Peptides having atrial natriuretic factor activity Grant 5,204,328 - Nutt , et al. April 20, 1 | 1993-04-20 |
Humoral hypercalcemic factor antagonists Grant 5,114,843 - Rosenblatt , et al. May 19, 1 | 1992-05-19 |
Antagonists with position 13 modification Grant 5,093,233 - Rosenblatt , et al. * March 3, 1 | 1992-03-03 |
Peptides having ANF activity Grant 5,091,366 - Nutt , et al. February 25, 1 | 1992-02-25 |
Humoral hypercalcemic factor antagonists with modification at position 13 . . . Grant 5,087,562 - Rosenblatt , et al. February 11, 1 | 1992-02-11 |
Fibrinogen receptor antagonists Grant 5,061,693 - Nutt , et al. October 29, 1 | 1991-10-29 |
Peptides having ANF activity Grant 5,057,603 - Nutt , et al. October 15, 1 | 1991-10-15 |
Fibrinogen receptor antagonists Grant 5,023,233 - Nutt , et al. June 11, 1 | 1991-06-11 |
Piptides having ANF activity Grant 4,816,443 - Brady , et al. March 28, 1 | 1989-03-28 |
Parathyroid hormone antagonists with simplified synthetic methodology Grant 4,771,124 - Rosenblatt , et al. September 13, 1 | 1988-09-13 |
Novel cyclic tetrapeptide Grant 4,703,034 - Freidinger , et al. October 27, 1 | 1987-10-27 |
Cyclic hexapeptide somatostatin analogs Grant 4,612,366 - Nutt September 16, 1 | 1986-09-16 |
Bicyclic somatostatin analogs Grant 4,191,754 - Veber , et al. March 4, 1 | 1980-03-04 |
Cyclization of peptides Grant 4,102,877 - Nutt July 25, 1 | 1978-07-25 |
Synthetic antigens of luteinizing hormone releasing hormone Grant 3,963,691 - Hoffman , et al. June 15, 1 | 1976-06-15 |
Analogs of thyrotropin-releasing hormone Grant 3,959,248 - Veber , et al. May 25, 1 | 1976-05-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.